That is necessary, because the way a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be reliable. Simply put, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (jeff brown investor prediction). Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much simpler to create drugs that do what they're developed to do. This was a breakthrough practically no one noticed. But it's going to have extensive ramifications for treating disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be plenty of investment chances in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown prediction). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it pulled back maybe substantially prior to going higher - melania trump. I have actually been covering bitcoin for a long period of time now. Among the very first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were primarily informing readers. However that's not the big concern anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. jeff brown investor prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are many great private business on the edge of hitting the general public markets And I have actually been dealing with a new method for you to invest even before these companies go public.
This chance has been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the details. Go right here to book your area totally free.
Emma Walsh here, managing editor of the Diary. Routine Diary readers understand that tech isn't our usual beat (jeff brown prediction). And when it comes to tech investing, we leave it to the specialists. Luckily, we have a number of such specialists in our Rolodex. Our colleague Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing specialists we understand (jeff brown biotech stock). In fact, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge image and forecast what's simply around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and a lot more. These trends are experiencing rapid development and creating incredible opportunities for investors. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. united states. But despite what many readers may think, this is a pattern that's simply getting started. Despite the fact that the COVID-19 pandemic disrupted supply chains in 2015, an impressive 250 million 5G-enabled devices were still sold.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (bleeding edge). Losing 2 months of manufacturing and sales truly affects the number of 5G devices are offered in the calendar year. When you consider all of that, selling 250 million units is impressive. More significantly, the delays triggered by the pandemic developed a lots of pent-up need. And that need is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G devices will be delivered in 2021 - future report review. And that's not my only 5G prediction When I've discussed 5G in the past, I have actually explained its three various stages.
In Phase 2, 5G gadgets go on sale. 5G phones and other items begin to reach consumers. And in Phase 3, 5G services begin to be offered (the legacy report prediction). That's when we begin to see applications operating on 5G networks. Consider things like massive multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Stage Three by this summer. This starts something of a virtuous cycle: Many people do not really care about the innovation. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In truth, 5G is going to open up a suite of unbelievable applications: self-driving automobiles, the Web of Things, robotic surgery, and more. All of these technologies require 5G. The financial investment chances going forward will be huge. Stepping far from 5G, the next crucial innovation I foresee in 2021 is CRISPR hereditary editing. CRISPR represents "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it's one of the most exciting advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR uses a comparable concept however with our genetic code. "Typos" in our genome can cause illness. CRISPR can remedy these "typos." For years, CRISPR was primarily a niche technology that wasn't well understood. And throughout that time, there were truly just 3 companies running in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this technology just works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and providing extraordinary returns. This entire market is effectively a greenfield chance.
There's space for lots of companies to exist in this area. jeff brown predictions for 2021. And there will be more. That's my forecast for CRISPR in 2021. I predict that two or three more genetic modifying business will hold their IPOs. Sticking with biotechnology, we are seeing amazing things occurring at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its most current Alpha, Fold software application can properly predict the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That's essential because the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has been an experimental procedure. Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're designed to do. And here's my next prediction. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however numerous drug treatments produced using this innovation. This was one of those developments that almost no one saw. However it's going to have extensive ramifications for curing illness. And, naturally, there will be plenty of investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back maybe substantially before going greater. I've been covering bitcoin for a long time now. Among the first research reports I ever released was on bitcoin - jeff brown stock predictions. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. However at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
But nobody is asking that question any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. tech stock. Mass, Mutual is a 150-year-old organization. So think about that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the details depends on date as of February 2021, but we could not separately validate this claim. Offered Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like capability to select winning innovation stocks. He spent more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an excellent viewpoint on the market. He's constantly on the hunt for brand-new chances, and he shares a lot of his best picks in the Future Report.
That's high praise, but it's not ridiculously reasoned. Brown has an exceptional reputation as a stock-picker, and he effectively anticipated some of the biggest financial occasions of the previous twenty years. Although he doesn't appear to launch his picks to the general public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it ideal whenever, but Jeff Brown's precise forecasts have actually earned him legions of dedicated followers. That states a lot about his capability. The Near Future Report is released by Brownstone Research study, a popular monetary research publisher. Brownstone Research provides a number of research study services with a wide range of expertises - second wave.
The business is also affiliated with Bonner & Partners, another well-respected research study publisher - the legacy report prediction. On its site, Brownstone states its objective is to supply retail investors with professional-grade research study: "For too long, the very best financial investment research has actually not been offered to specific investors. It has been usually reserved for financial investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown investment prediction. The objective of Brownstone Research is to make that kind of proprietary research available to any investors aiming to acquire an edge in the markets. The goal is easy to deliver distinct and successful investment research study discovered nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise functions as the firm's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After decades of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout the majority of America. If you understand even a bit about the marketplace, you understand that he has a track record as a King Midas of sorts. longtime readers. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In reality, Brown thinks S.A.V. jeff brown biotech stock pick for 2020. could be "the greatest pattern of the 2020s, and he's not alone. Inspect out these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding 2 cutting-edge technologies: artificial intelligence and electric vehicles. Musk hopes the combination will help him establish the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing except the automobile industry's Holy Grail. As you know, electrical vehicles and self-driving cars and truck stocks have been big this year, but the Wall Street machine has been big on hype without much concrete outcome. In spite of an extreme boost in competition over the past couple of years, Brown still believes Musk has the finest chance of putting everything together.
tech might be the magic string that connects it all together. S.A.V. means Shared Autonomous Car, and it might be the future of transportation. Basically, this technology would allow you to lease out your car as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the car and press a button on an app that tells the cars and truck to "join the fleet." Next thing you understand, you're relaxing on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a hefty piece of the profits. It sounds ridiculous, however it could be closed than you believe.